Biomedicine & Pharmacotherapy · 2022 · 15 citations · 34 references
MedicineOncologyPharmacologyApoptosisChemotherapyMolecular OncologyApoptosis In CancerCytotoxic ChemotherapyMalignant NeoplasmsOncology PharmacologyOxidative Stress In CarcinogenesisReactive Oxygen SpeciesAnticancer ActivityAnticancer ChemotherapyAntineoplastic Drug TherapyMitochondrial Membrane Potential CollapseMitochondrial Reactive Oxygen Species ProductionMitochondrial Reactive Oxygen Species SignalingOxidative Stress In CancerReactive Oxygen Species-induced Apoptosis
BACKGROUND: Cancer remains one of the leading causalities of several morbidity and mortality with negative impact on global economy due to low workforce and management/treatment cost. A number of conventional therapies have been explored in the management/treatment of cancer including chemotherapeutic intervention, radiotherapy, and surgery. Among these treatment modalities, chemotherapy remains the most popular first line of intervention in management/treatment of cancer, and natural products have been implicated as the main source of antineoplastic agents with phenomenal efficacy. However, current antineoplastic agents suffer from lack of selectivity and specificity necessitating the need for further research in the search for novel anticancer drug molecules. METHODS: D NMR spectroscopy. The cell viability, colony formation, and apoptotic activities were investigated using MTT assay, clonogenic assay, and caspase - 3 and - 7 kits respectively. Flow cytometry was employed in assessing the altered cell cycle expression. The production of the intracellular reactive oxygen species (ROS) levels and the reduction of the mitochondrial membrane potential (MMP) was determined at the cellular level using fluorescent probe dyes dihydro-fluorescin diacetate (DCFH-DA) and tetramethylrhodamin (TMRE), respectively. RESULTS: The H. opposita fractions and its pure isolate (hoslundin) demonstrated a potent cytocidal activity against the tumorigenic cells (HepG2, MDA-MB-231, Caco-2) at concentration ranging from 25 to 100 µg/mL. The inhibition of the colony formation was significantly observed in HepG2 cell lines. More so, the cellular viability of the normal cells (HaCaT) was relatively unchanged in the presence of H. opposita fractions and its isolate proving the selectivity of the compounds towards tumourigenic cells. The H. opposita fractions and hoslundin exerted their anticancer activity via cell cycle arrest with the accumulation of the DNA content at the S-phase, activation of apoptosis in the caspase 3,7 activities and depolarized mitochondrial membrane potential mediated by mitochondrial-dependent ROS generation in the treated tumor cells. CONCLUSION: The anticancer activities of Hoslundia opposita Vahl and hoslundin exhibited significant efficacy against tumor cells and well tolerated in the presence of normal cells making them a potential antineoplastic agent.
34
Mitochondria-Ros Crosstalk in the Control of Cell Death and Aging
Saverio Marchi, Carlotta Giorgi, Jan M. Suski et al. · Journal of Signal Transduction · 2011 · 646 citations · Full text
Evaluating Medicinal Plants for Anticancer Activity
Elisha Solowey, Michal Lichtenstein, Sarah Sallon et al. · The Scientific World JOURNAL · 2014 · 314 citations · Full text